Alzheimer's disease
Mohammad Sultan Khan, a 34-year-old researcher from Kashmir, has made significant findings in his seven-year study on the effects of disturbed sleep and irregular body clocks on brain aging and memory loss, especially in Alzheimer's disease. His research, conducted at the University of Hyderabad's neurobiology and
Advertising executives
A new report has shed light on the genetic underpinnings of two distinct neurological conditions: attention-deficit/hyperactivity disorder (ADHD) and Alzheimer's disease (AD). According to the research, emerging evidence suggests a potential intersection between the two conditions, with overlapping contributors such as synaptic plasticity, neuroinflammation, and oxidative stress.
Alzheimer's disease
Mohammad Sultan Khan, a 34-year-old researcher from Kashmir, has made significant findings in his seven-year study on the effects of disturbed sleep and irregular body clocks on brain aging and memory loss, especially in Alzheimer's disease. His research, conducted at the University of Hyderabad's neurobiology and
Alzheimer's disease
Mohammad Sultan Khan, a 34-year-old researcher from Kashmir, has made significant findings in his seven-year study on the effects of disturbed sleep and irregular body clocks on brain aging and memory loss, especially in Alzheimer's disease. His research, conducted at the University of Hyderabad's neurobiology and
Alzheimer's disease
For many families, being diagnosed with Alzheimer's disease or dementia is a devastating reality. The emotional toll on both the individual and their loved ones can be overwhelming. Fearful, a 67-year-old woman, is struggling to cope with her mother's diagnosis and her own fear of developing
Diseases
Research conducted at Johns Hopkins Medicine has revealed that mammalian brains create networks of nanotubes to transport toxins, including amyloid-beta, out of brain cells. This process may lead to a better understanding of Alzheimer's disease and potentially pave the way for new therapies. Using genetically engineered mice and
Alzheimer's disease
As a 67-year-old individual, facing the diagnosis of Alzheimer's disease in loved ones can be daunting. The fear of succumbing to the same condition is overwhelming, prompting questions about the best course of action. For Fearful, who is visiting his 92-year-old mother in a care home, the pain
Alzheimer's disease
As a 67-year-old individual, facing the diagnosis of Alzheimer's disease in loved ones can be daunting. The fear of succumbing to the same condition is overwhelming, prompting questions about the best course of action. For Fearful, who is visiting his 92-year-old mother in a care home, the pain
Alzheimer's disease
Rodney Scott, Division Chief of Neurology at Nemours Children's Health, has been awarded a $2.6 million, five-year grant to investigate malfunctions in the brain's hippocampal region, aiming to identify patterns that could lead to shared therapies for patients with autism, epilepsy, and Alzheimer's
Alzheimer's disease
As a 67-year-old individual, facing the diagnosis of Alzheimer's disease in loved ones can be daunting. The fear of succumbing to the same condition is overwhelming, prompting questions about the best course of action. For Fearful, who is visiting his 92-year-old mother in a care home, the pain
Alzheimer's disease
Research conducted at Johns Hopkins Medicine has revealed that mammalian brains create networks of nanotubes to transport toxins, including amyloid-beta, out of brain cells. This process may lead to a better understanding of Alzheimer's disease and potentially pave the way for new therapies. Using genetically engineered mice and
Diseases
Rodney Scott, Division Chief of Neurology at Nemours Children's Health, has been awarded a $2.6 million, five-year grant to investigate malfunctions in the brain's hippocampal region, aiming to identify patterns that could lead to shared therapies for patients with autism, epilepsy, and Alzheimer's
